Marconato, L.; Tiraboschi, L.; Aralla, M.; Sabattini, S.; Melacarne, A.; Agnoli, C.; Balboni, A.; Salvi, M.; Foglia, A.; Punzi, S.;
et al. A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy. Cancers 2023, 15, 4209.
https://doi.org/10.3390/cancers15174209
AMA Style
Marconato L, Tiraboschi L, Aralla M, Sabattini S, Melacarne A, Agnoli C, Balboni A, Salvi M, Foglia A, Punzi S,
et al. A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy. Cancers. 2023; 15(17):4209.
https://doi.org/10.3390/cancers15174209
Chicago/Turabian Style
Marconato, Laura, Luca Tiraboschi, Marina Aralla, Silvia Sabattini, Alessia Melacarne, Chiara Agnoli, Andrea Balboni, Marta Salvi, Armando Foglia, Sofia Punzi,
and et al. 2023. "A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy" Cancers 15, no. 17: 4209.
https://doi.org/10.3390/cancers15174209
APA Style
Marconato, L., Tiraboschi, L., Aralla, M., Sabattini, S., Melacarne, A., Agnoli, C., Balboni, A., Salvi, M., Foglia, A., Punzi, S., Romagnoli, N., & Rescigno, M.
(2023). A Phase 2, Single-Arm, Open-Label Clinical Trial on Adjuvant Peptide-Based Vaccination in Dogs with Aggressive Hemangiosarcoma Undergoing Surgery and Chemotherapy. Cancers, 15(17), 4209.
https://doi.org/10.3390/cancers15174209
